JANE STREET GROUP, LLC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 69 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$81,089
-53.2%
21,452
-17.0%
0.00%
Q2 2023$173,148
-80.6%
25,843
-81.2%
0.00%
Q1 2023$894,800
+433.7%
137,450
+599.2%
0.00%
Q4 2022$167,674
+123.6%
19,657
+38.6%
0.00%
Q3 2022$75,000
-73.3%
14,183
+55.7%
0.00%
Q2 2021$281,000
-68.1%
9,111
-52.1%
0.00%
Q4 2020$882,00019,0380.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$12,721,0003.35%
Orbimed Advisors 8,740,887$58,214,0000.75%
Nantahala Capital Management 1,006,462$6,703,0000.24%
EcoR1 Capital, LLC 1,060,010$7,060,0000.22%
Prosight Management, LP 53,815$358,0000.21%
RA Capital Management 1,742,186$11,603,0000.20%
Endurant Capital Management LP 84,295$561,0000.14%
HighVista Strategies LLC 22,434$149,0000.12%
XTX Topco Ltd 18,816$125,0000.07%
WASATCH ADVISORS LP 1,773,690$11,813,0000.05%
View complete list of SILVERBACK THERAPEUTICS INC shareholders